
David Turok
Training Integration Core Lead · Univ of Utah Sch of Med
Credentials: · · · · · ·
History
PresentUniv of Utah Sch of Med · Huntsman Cancer Institute & Hospital



- 1995–1996
1991–1995- 1987–1991
Research
Women s Health Issues · 2012 · Last of 5 authors · 90 citations
Levonorgestrel vs. Copper Intrauterine Devices for Emergency Contraception
New England Journal of Medicine · 2021 · First of 8 authors · 86 citations
Three-year efficacy and safety of a new 52-mg levonorgestrel-releasing intrauterine system
Contraception · 2015 · 80 citations

42 papers

14 papers · 4 as a fellow
- JJ
13 papers

11 papers

10 papers · 2 as a fellow

10 papers
- AD
8 papers · 7 as a fellow

8 papers
Grants
- 2023–2030
ELEVATE Center: Reduction of Maternal Morbidity from Substance Use Disorder in Utah
National Institute of Child Health and Human Development · U54
Project lead · $1.1M · Utah State Higher Education System--University of Utah
- 2024–2029
Research Training Program in Reproductive and Sexual Health
National Institute of Child Health and Human Development · R25
PI · $473.6K · Utah State Higher Education System--University of Utah
- 2015–2027
Levonorgestrel IUD for Emergency Contraception & Same-Day Start Study
National Institute of Child Health and Human Development · R01
Contact PI · $3.6M · Utah State Higher Education System--University of Utah
- 2020–2026
National Institute of Child Health and Human Development · N01
Contact PI · $134.4K · Columbia University Health Sciences
Clinical trials
- 2027–2031
Rct Assessing Pregnancy - Piroxicam for Ec With Levonorgestrel
Principal investigator · Not yet recruiting · Phase 3
University of Utah
- 2022–2027
Levonorgestrel 52 mg IUD for Emergency Contraception and Same-Day Start
Principal investigator · Recruiting · Phase 4
University of Utah
- 2022–2025
Atorvastatin as a Potential Adjunct to Misoprostol for Termination of Pregnancy
Principal investigator · Completed · Early phase 1
University of Utah
- 2021–2022
Letrozole and Misoprostol for Termination of Pregnancy up to 63 Days' Gestation
Principal investigator · Completed · Phase 2
Gynuity Health Projects

